AT THE HEART OF QUALITY ACTIVE PHARMACEUTICAL INGREDIENTS SINCE 1990
Company Overview
- Established in Hyderabad, India, over 30 years ago, Divi’s Laboratories operates three state-of-the-art manufacturing facilities and is recognised as one of India’s leading pharmaceutical companies.
- Ranked among the top 3 API manufacturers globally, Divi’s also stands at the forefront of sustainable chemistry.
- Divi’s is globally known as a ‘Reliable Supplier of Generic APIs’ and preferred as a trusted ‘Custom Manufacturer’ for Big Pharma, offering the highest quality products and services across the entire drug development lifecycle.
- Divi’s is the leading manufacturer of high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, and Registered Starting Materials, supplying to over 100 countries with unmatched compliance, consistency, and integrity.
- With a workforce of ~20,100 highly trained professionals and ~700 scientists, Divi’s combines deep scientific expertise with robust infrastructure to deliver world-class pharmaceutical ingredients to global customers.
- As a publicly listed company on the Indian stock exchange, Divi’s reported a revenue of ~$1.1 billion for FY 2024–25.
- Divi’s manufacturing facilities in Hyderabad and Visakhapatnam have undergone multiple inspections by leading health authorities, including USFDA, EU GMP (UK, Slovenia, Germany, Ireland), HEALTH CANADA, TGA, ANVISA, COFEPRIS, PMDA, and MFDS.
Vision
We envision creating value for all stakeholders by manufacturing high quality Generic APIs, Custom synthesis of APIs & Intermediates along with Nutraceutical Ingredients to the Global Pharmaceutical & Nutraceutical industry through sustainable leadership in chemistry.
Mission
We at Divi’s aim to be a responsible business, adding value through our core competency in the area of chemistry while adhering to our core values and serving the immediate community and at large through our diverse social initiatives that would establish a strong foundation for a better tomorrow for all stakeholders.